Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Grande Portage Resources (V.GPG) Initiates Sensor-Based Ore Sorting Testwork (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Heart Test Laboratories Equity Warrant Exp 15th June 2027 HSCSW

HeartSciences Inc. is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The Company has libraries of artificial intelligence-enhanced electrocardiography (AI-ECG) algorithms and is developing AI-ECG solutions to be made available on either a hardware- agnostic cloud-based platform or its... see more

Recent & Breaking News (NDAQ:HSCSW)

HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting

GlobeNewswire January 18, 2024

HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting

GlobeNewswire January 3, 2024

HeartSciences Reports Second Quarter Fiscal 2024 Financial Results

GlobeNewswire December 14, 2023

HeartSciences Receives FDA Confirmation for 510(k) Clearance Pathway

GlobeNewswire December 5, 2023

HeartSciences Announces Closing of License Agreements with the Icahn School of Medicine at Mount Sinai to Develop and Commercialize AI Cardiovascular Algorithms

GlobeNewswire November 20, 2023

HeartSciences' MyoVista® wavECGTM Selected for Heart Screening of Irish Garda National Police Officers

GlobeNewswire November 13, 2023

HeartSciences Issues Investor Update Highlighting Recent Key Achievements and Positive Developments

GlobeNewswire October 19, 2023

HeartSciences Receives Two New Patent Allowances, Expanding its International Patent Portfolio

GlobeNewswire September 26, 2023

HeartSciences to Participate in the Maxim Group Virtual Tech Conference Series: Emerging Growth in A.I.

GlobeNewswire September 25, 2023

HeartSciences Signs Definitive Agreements with the Icahn School of Medicine at Mount Sinai to Commercialize Artificial Intelligence Cardiovascular Algorithms

GlobeNewswire September 21, 2023

HeartSciences Reports First Quarter Fiscal 2024 Financial Results

GlobeNewswire September 14, 2023

HeartSciences to Present at the Gilmartin Group Emerging Growth Showcase

GlobeNewswire September 12, 2023

HeartSciences Named Electrocardiography Advancement Specialists of the Year 2023 - USA in the Global Health & Pharma Excellence Awards

GlobeNewswire September 11, 2023

HeartSciences Signs Distribution Agreement with MedPhy Technologies, Mumbai, India

GlobeNewswire September 7, 2023

HeartSciences Signs Distribution Agreement with FJ Medical, Denmark

GlobeNewswire August 31, 2023

HeartSciences' MyoVista® wavECGTM Selected to be used in Irish Heart Screening Evaluation

GlobeNewswire August 24, 2023

HeartSciences Announces Further Expansion of Artificial Intelligence (AI) Patent Portfolio

GlobeNewswire August 17, 2023

MyoVista wavECG goes into clinical use at the Naya Imaging Center in Denmark

GlobeNewswire July 27, 2023

HeartSciences Provides Business Update and Reports Fiscal 2023 Financial Results

GlobeNewswire July 19, 2023

HeartSciences Named as a Top 10 Healthcare Artificial Intelligence Solutions Provider 2023 by Healthcare Tech Outlook Magazine

GlobeNewswire May 17, 2023